We offer knockout, knock-in, and conditional knockout rats.
Rats, being larger than mice and more physiologically and genomically similar to humans, are suitable models for human-related biomedical and clinical research. Rat models are widely used in toxicology, endocrinology, oncology, cardiovascular research, dental research, and experimental parasitology. While there are many limitations to gene modification techniques using ES cells, our company has overcome these limitations with our proprietary technology. We offer knockout rats, knock-in rats, and point mutation rats with a 100% guarantee at promotional prices. 【List of Services】 ■ SD Knockout Rats ■ SD Point Mutation Rats ■ SD Knock-in Rats ■ SD Conditional Knockout Rats *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【About the Campaign】 ■Target: Customers in Japan ■Free Shipping: Free delivery to customers' animal facilities ■Create rats at a great price *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
In 2005, we were established as a contract research organization for pharmaceutical development and a manufacturer of cell-related products. Currently, we have 400 employees worldwide. Our headquarters is located in Silicon Valley, California, USA, with manufacturing bases in Suzhou and Guangzhou, China. In 2016, we opened a branch in Tokyo, Japan. As a leading company in the production of genetically modified animal models, we provide high-quality reagents and tools at reasonable prices. 1. Production of genetically modified animal models: As a leading company in the contract production of rodent animal models, we offer a one-stop service that is optimal for research. Our services cover a wide range, including vector construction, ES cell manipulation, and microinjection production, allowing us to accept contracts for animal model production at any stage of the process. We are also engaged in contract services for animal models using the CRISPR-Cas9 system and artificial nuclease technology. The artificial nuclease technology can save time and costs compared to traditional gene targeting techniques.